C07C 313/18
Sulfenamides
C07C313/18 (Sulfenamides) appears on 78 US grants and 21 published applications in this corpus.
Search patents in C07C- Granted patents
- 78
- Published applications
- 21
- Assignees
- 45
- Inventors
- 193
- Latest grant
- 26 Nov 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 3 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 2 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 3 | 0 |
| 1984 | 2 | 0 |
| 1985 | 7 | 0 |
| 1986 | 1 | 0 |
| 1987 | 3 | 0 |
| 1988 | 1 | 0 |
| 1989 | 3 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 4 | 0 |
| 1995 | 1 | 0 |
| 1996 | 4 | 0 |
| 1997 | 2 | 0 |
| 1998 | 4 | 0 |
| 1999 | 3 | 0 |
| 2000 | 2 | 0 |
| 2001 | 4 | 0 |
| 2002 | 3 | 0 |
| 2003 | 2 | 3 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 1 | 0 |
| 2007 | 1 | 1 |
| 2008 | 2 | 2 |
| 2009 | 0 | 1 |
| 2010 | 1 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 4 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 3 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 1 |
| 2020 | 1 | 0 |
| 2021 | 0 | 0 |
| 2022 | 1 | 1 |
| 2023 | 0 | 1 |
| 2024 | 1 | 3 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
- C07C 313/26Compounds containing any of the groups [image cpc-sch-c07c-0978.gif], x being a hetero52
- C07C 313/20Having sulfur atoms of sulfenamide groups bound to acyclic carbon atoms11
- C07C 313/36Having nitrogen atoms of sulfenamide groups further bound to other hetero atoms7
- C07C 313/24Having sulfur atoms of sulfenamide groups bound to carbon atoms of six-membered3
- C07C 313/22Having sulfur atoms of sulfenamide groups bound to carbon atoms of rings0
- C07C 313/38N-sulfenylisocyanates0
Recent patents
- Process for making a pharmaceutical compound26 Nov 2024US 12,152,000 B2Adeptio Pharmaceuticals Limited
- Synthetic process17 May 2022US 11,332,442 B2Bristol-Myers Squibb Company
- Inhibitors of creatine transport and uses thereof21 Jul 2020US 10,717,704 B2Rgenix, Inc.
- Inhibitors of creatine transport and uses thereof4 Jun 2019US 10,308,597 B2Rgenix, Inc.
- Chiral 2-arylpropyl-2-sulfinamide and chiral N-2-arylpropyl-2-sulfinylimines and synthesis thereof22 Dec 2015US 9,216,953 B2
- Novel compound for capping layer and organic light emitting device including same22 Aug 2024US 2024/0279158 A1Dongjin Semichem Co., Ltd.
- Compound for capping layer and organic light emitting device including same13 Jun 2024US 2024/0190810 A1Dongjin Semichem Co., Ltd.
- Compound for capping layer and organic light emitting device including same16 May 2024US 2024/0164138 A1Dongjin Semichem Co., Ltd.
- Process for making a pharmaceutical compound19 Oct 2023US 2023/0331667 A1Adeptio Pharmaceuticals Limited
- Synthetic process17 Feb 2022US 2022/0048859 A1Bristol-Myers Squibb Company
Most cited
By later US patents
- Amorphous tetrafluoroethylene-hexafluoropropylene copolymers54US 5,663,255 AE. I. Du Pont de Nemours and Company · 1997
- Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders51US 5,824,669 ANitroMed, Inc. · 1998
- GnRH analogs44US 5,296,468 AThe Salk Institute for Biological Studies · 1994
- Amorphous tetrafluoroethylene-hexafluoropropylene copolymers41US 6,133,389 AE. I. Du Pont de Nemours and Company · 2000
- Amorphous tetrafluoroethylene/hexafluoropropylene copolymers36US 5,478,905 AE. I. Du Pont de Nemours and Company · 1995